Cantourage Group SE
HIGH | XMIL
Overview
Corporate Details
- ISIN(s):
- DE000A3DSV01
- LEI:
- 3912003NCTLO6YHA9V48
- Country:
- Germany
- Address:
- Feurigstraße 54, 10827 Berlin
- Website:
- https://www.cantourage.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Cantourage Group SE is a leading European medical cannabis company that produces and distributes cannabis-based medicinal preparations. Founded in 2019, the company operates a 'fast-track' platform model, sourcing cannabis flowers and raw materials from a global network of cultivation partners. It manages the import and processing of these materials into EU-compliant pharmaceutical products at its European manufacturing hubs, handling all regulatory complexities. The product portfolio includes dried flowers, extracts, dronabinol, and pharma-grade cannabidiol, which are distributed to pharmacies through wholesalers. Cantourage also facilitates patient access to medical cannabis therapies through its telemedicine platform, Telecan.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Cantourage Group SE.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-09 18:42 |
Board/Management Information
Ad-hoc-Mitteilung nach Art. 17 Marktmissbrauchsverordnung - Cantourage Group SE…
|
German | 4.6 KB | |
| 2025-05-20 07:51 |
Earnings Release
Cantourage achieves strong and profitable growth in the first quarter of 2025
|
English | 7.4 KB | |
| 2025-05-15 07:07 |
Earnings Release
Cantourage achieves another record revenue: EUR 11.1 million in April 2025
|
English | 6.6 KB | |
| 2025-04-11 09:03 |
Earnings Release
Ad-hoc: Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 202…
|
English | 6.8 KB | |
| 2025-04-10 08:52 |
Earnings Release
Record quarter for Cantourage-Group: EUR 25.6 million revenue in Q1 for the fi…
|
English | 9.0 KB | |
| 2025-03-11 08:31 |
Earnings Release
Cantourage Group SE: Starker Jahresendspurt und anhaltendes Wachstum in 2025
|
German | 7.6 KB | |
| 2025-03-10 08:31 |
Earnings Release
Cantourage Group SE: Starker Jahresendspurt und anhaltendes Wachstum in 2025
|
German | 7.6 KB | |
| 2025-01-16 07:30 |
Earnings Release
Legalization of cannabis brings strong growth: Cantourage Group SE increases it…
|
English | 10.0 KB | |
| 2025-01-15 07:31 |
Earnings Release
Cantourage Group SE ubertrifft Prognose und steigert Umsatz um 118 % auf EUR 51…
|
German | 8.0 KB | |
| 2025-01-15 07:30 |
Earnings Release
Legalization of cannabis brings strong growth: Cantourage Group SE increases it…
|
English | 11.2 KB | |
| 2025-01-14 07:31 |
Earnings Release
Cantourage Group SE ubertrifft Prognose und steigert Umsatz um 118 % auf EUR 51…
|
German | 8.0 KB | |
| 2024-12-20 08:00 |
M&A Activity
Cantourage Group SE exports medical craft cannabis for the first time to the gr…
|
English | 10.6 KB | |
| 2024-12-19 08:00 |
Regulatory News Service
Cantourage Group SE exports medical craft cannabis for the first time to the gr…
|
English | 10.6 KB | |
| 2024-12-13 08:00 |
Earnings Release
Cantourage Group SE verzeichnet starke Geschaftsentwicklung im November und erh…
|
German | 11.1 KB | |
| 2024-12-12 08:00 |
Earnings Release
Cantourage Group SE verzeichnet starke Geschaftsentwicklung im November und erh…
|
German | 11.1 KB |
Automate Your Workflow. Get a real-time feed of all Cantourage Group SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Cantourage Group SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-02-14 | Think.Health Projekt M GmbH & Co. KG | Close relation | Sell | None | 4,005.00 EUR |
| 2023-09-07 | CDXX Vermögens- und Verwaltungs GmbH | Close relation | Sell | None | 105,490.00 EUR |
| 2023-08-17 | HOFY4 GmbH | Close relation | Sell | None | 40,023.24 EUR |
| 2023-08-17 | HOFY4 GmbH | Close relation | Sell | None | 14,257.90 EUR |
| 2023-06-20 | HOFY4 GmbH | Close relation | Sell | None | 80,519.46 EUR |
| 2023-06-14 | HOFY4 GmbH | Close relation | Sell | None | 1,658.50 EUR |
